BSX · NYSE · STOCK
Boston Scientific (BSX) Stock Analysis
$42.74
52W $41.39 – $105.65
62/100
$63.51B
17.2
0.57
Is BSX Bullish or Bearish?
Bullish.
Innellis AI committee rates Boston Scientific (BSX) Buy with a composite score of 62/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.47 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.53 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 46.8% yoy. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- EPS growing 46.8% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Price-to-book of 5.8x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
62/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 24%
of 192 Healthcare peers
Value Analyst
neutral
53
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− Price-to-book of 5.8x prices in significant intangible value
Growth Analyst
bullish
79
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 46.8% YoY
Technical Analyst
neutral
49
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 61.5 to 61.5.
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
44.2
Neutral
MACD Histogram
-0.021
Bearish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Support
$42.20
Resistance
$43.52
Bollinger %B
0.30
Inside Bands
Price vs Moving Averages
EMA 9
$42.70
Above
EMA 21
$43.68
Below
EMA 50
$45.41
Below
EMA 200
$58.93
Below
Fundamental Analysis
Valuation
92
Growth
78
Profitability
78
Financial Health
68
Cash Flow
70
Valuation
P/E Ratio
17.2×
P/B Ratio
2.53×
PEG Ratio
0.38
Dividend Yield
0.00%
52W High
$105.65
52W Low
$41.39
Quality & Growth
ROE
1190.9%
ROA
660.8%
Gross Margin
7115.6%
Operating Margin
2146.1%
Revenue Growth YoY
—
Debt / Equity
0.51
AI Fundamental Assessment
P/E ratio of 17.2 (inexpensive relative to a 15-40x range); Price-to-book of 2.5x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.9%; Return on assets of 6.6%; Net margin of 17.5%; Gross margin of 71.2%; Current ratio of 1.24 (tight short-term liquidity); Debt-to-equity of 0.51; Free cash flow per share is positive (2.45); Most recent quarter beat estimates by 2.9%; 5 consecutive earnings beats; EPS growth accelerating (+0.0% -> +7.5% QoQ); Average YoY EPS growth of 14.7%; Analyst estimates rising over recent quarters
Get the Full BSX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →